Clinical trial
Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation
NCT00224341 · Vitatron France, Industry · Unknown status
Key facts
| NCT number | NCT00224341 |
|---|---|
| Title | Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation |
| Lead sponsor | Vitatron France, Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sick Sinus Syndrome, Brady-Tachy Syndrome |
| Intervention type | Device |
| Interventions | Pacemaker Vitatron Selection 9000, Pacemaker Vitatron T70 |
| Enrollment | 360 |
| Start date | Nov 1, 2003 |
| Completion | Nov 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 18, 2006 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: